NCT02139839View on ClinicalTrials.gov

Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Vaginosis, Bacterial
Interventions
OTHER

Lactobacillus capsules

L. rhamnosus GR-1 and L. reuteri RC-14 capsules manufactured by Chr. Hansen

DRUG

Placebo gelatin pill

Placebo Comparator capsules, identical in appearance to the active product; 98% Gelatin with no L. rhamnosus GR-1 and L. reuteri RC- 14.

Trial Locations (1)

N6J 0A8

Dorli Herman, London

Sponsors

Collaborators (1)

Integrated Research Inc.
All Listed Sponsors
collaborator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

collaborator

Western University, Canada

OTHER

collaborator

Integrated Research Inc.

INDUSTRY

lead

Kimberly-Clark Corporation

INDUSTRY

NCT02139839 - Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14 | Biotech Hunter | Biotech Hunter